JNJ Exec Sells $4.2M in Stock Following Option Exercise
JOHNSON & JOHNSON
Subscribe to track JNJ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
JNJ Exec Sells $4.2M in Stock Following Option Exercise
Company: JOHNSON & JOHNSON (JNJ) Form: 4 | Filed: 2025-10-20 Significance: Low
Insider: REED JOHN C Title: EVP, Innovative Medicine, R&D | Relationship: Officer
Transaction: • Type: Sell (following option exercise) • Shares: 21,721 • Price: $192.71 • Value: $4,186,162 • Owned After: 10,658
Key Insight: An executive exercised stock options and immediately sold the shares, a common practice for compensation and tax purposes. The transaction value is negligible compared to JNJ's market cap.
Market Context: This is a routine executive compensation event for a mega-cap company and is not considered a bearish signal on its own.
Comprehensive Analysis
SEC Filing Analysis: JOHNSON & JOHNSON (JNJ)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An executive at Johnson & Johnson conducted a common 'cashless exercise' of stock options, acquiring 21,721 shares at $157.92 and immediately selling them for a total of $4.2 million at an average price of $192.71.
- Market Impact: The transaction is immaterial relative to Johnson & Johnson's $465 billion market capitalization and is unlikely to have any impact on the stock price.
Company Information
| Field | Value |
|---|---|
| Company | JOHNSON & JOHNSON |
| Ticker Symbol | JNJ |
| CIK | 0000200406 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | REED JOHN C |
| CIK | 0001181561 |
| Title/Position | EVP, Innovative Medicine, R&D |
| Relationship | Officer |
Transaction Details
This filing reports two related non-derivative transactions: an option exercise and a subsequent sale.
| Field | Value (Sale Transaction) |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-17 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 21,721 |
| Price Per Share | $192.71 |
| Total Value | $4,186,161.85 |
| Shares Owned After | 10,658 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $4,186,161.85 |
| % of Market Cap | 0.0009% |
| Shares Transacted | 21,721 |
| % of Shares Outstanding | 0.0009% |
| Post-Transaction Ownership | 10,658 shares (0.00044% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a mega-cap company like Johnson & Johnson with a market capitalization of $465.34 billion, a $4.2 million transaction is financially insignificant and represents a tiny fraction of daily trading volume.
- Ownership Concentration: The insider's final holding of 10,658 shares is a negligible percentage of the total shares outstanding, indicating very low ownership concentration from this individual.
- Dilution Impact: The transaction originated from an option exercise, which introduces 21,721 new shares. This represents a 0.0009% increase in shares outstanding, which is a completely immaterial dilution event for existing shareholders.
- Transaction Significance: The sale liquidated approximately 67% of the shares the insider held after the option exercise (21,721 sold out of 32,379). While a large percentage of the insider's personal holdings, the overall size is too small relative to the company's scale to be considered significant. This is a typical strategy to cover the option exercise cost, pay taxes, and realize a profit.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is a routine executive compensation event. The market understands that 'exercise-and-sell' transactions are often pre-planned and not indicative of an insider's negative outlook on the company's future.
Volume & Sentiment
- Expected Volume Impact: None. The transaction size is too small to affect JNJ's typical trading volume.
- Sentiment Indicator: Neutral. This type of filing is common and does not typically influence market sentiment for a company of this size.
Investment Insights
Positive Market Indicators
- The exercise of options indicates the stock price is well above the strike price, reflecting past stock performance.
Risk Factors
- No new risk factors are indicated by this filing. The sale is not large enough to be considered a signal of concern.
Key Takeaways
- Routine Compensation: This is a standard executive compensation event, not a strategic investment decision.
- Immaterial Size: The transaction's value and share count are negligible compared to Johnson & Johnson's total market cap and shares outstanding.
- No Bearish Signal: The sale was directly tied to an option exercise and should not be interpreted as the insider losing faith in the company.
Additional Context
Transaction Notes
- Special Circumstances: The filing details a two-step process: exercising employee stock options to acquire shares (Code 'M') and then immediately selling those shares on the open market (Code 'S'). The sale price of $192.71 is a weighted average, as noted in the filing's footnotes.
- Market Environment: This transaction is a function of the executive's compensation plan and vesting schedule, rather than a reaction to current market conditions.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
